- Email:
Whole-Brain Organoid Service
Introduction
Animal models fail to reflect human brain features, limiting CNS drug development. Human iPSC‑derived whole‑brain organoids better recapitulate human neurobiology, and millifluidic systems improve neurogenesis and neurotransmitter production. Creative Biolabs' Whole‑Brain Organoid Service uses STEMOD™ AIOMP technology to generate stable, reproducible models with human‑specific oSVZ structure. It supports accurate neurotoxicity screening, drug assessment, and disease modeling for psychiatric and neurodegenerative disorders, improving clinical translation.
Discover How We Can Help - Request a Consultation →
Whole-Brain Organoid Service
Our Whole-Brain Organoid Service generates multi-region, self-patterned 3D brain models from human pluripotent stem cells. These organoids recapitulate key brain regions, global cytoarchitecture, and long-range neural connections, serving as a holistic platform for neurodevelopment, disease modeling, and drug discovery.
Key Brain Regions Recapitulated
| Region | Representative Markers |
|---|---|
| Forebrain / Cortex | FOXG1, PAX6, TBR1, SATB2 |
| Midbrain | EN1, EN2, LMX1A, TH |
| Hindbrain / Cerebellum | GBX2, HOXA2, ATOH1, PTF1A |
| Hippocampus | PROX1, ZBTB20 |
| Choroid plexus | TTR, AQP1 |
Core Differentiation Principle
- Minimal early patterning to enable self-organized regionalization
- Mild dual SMAD inhibition for stable neural induction
- No strong region-specific bias allows whole-brain-like structure formation
- Long-term maturation for cross-region circuit formation
Key Factors & Small Molecules
| Factor | Function |
|---|---|
| Dual SMAD inhibitors (SB43042, LDN) | Neural induction |
| Physiological oxygen (3-5% O2) | Improve survival & maturity |
| Neurotrophic factors (BDNF, GDNF) | Promote neuronal maturation |
| Extracellular matrix components | Support 3D structure & polarization |
Main Quality Control Indicators
- Regional marker expression across forebrain, midbrain, hindbrain
- Neural progenitor organization & neural rosette formation
- Apicobasal polarity & layered structure
- Neuronal maturity & synaptic marker expression
- Batch-to-batch uniformity & reproducibility
Major Applications
- Modeling global neurodevelopmental disorders
- Studying inter-regional axon projection and circuit formation
- Drug screening, neurotoxicity, and teratogenicity testing
- Patient-specific disease modeling & gene therapy validation
- Studying brain-wide viral infection or inflammation dynamics
Workflow
To initiate the service, clients typically provide Required Starting Materials such as specific iPSC lines (or samples for reprogramming), target gene sequences for CRISPR/Cas9 engineering, or specific drug compounds for high-throughput screening.
What We Can Offer
As a global leader in neuroscience research services, Creative Biolabs provides an end-to-end suite of whole-brain organoid solutions. We specialize in transforming complex biological requirements into reproducible, high-standard data. Our offerings include:
One-stop Organoid Generation
Full-scale service from initial iPSC reprogramming and CRISPR/Cas9 gene editing to long-term maturation and functional validation.
Scalable Customization
Flexible culture protocols tailored to your specific disease model or therapeutic area; we offer fully customized regional specialization (e.g., enrichment of dopaminergic or GABAergic lineages).
Proprietary Millifluidic Technology
Utilizing the AIOMP platform to ensure zero-transfer protocols, drastically reducing mechanical stress and morphological heterogeneity.
Well-Established Quality System
Integration of Quality-by-Design (QbD) and process analytical techniques (PAT) to monitor organoid growth and health in real-time.
Strict Aseptic Verification
Specialized clean-room facilities and rigorous contamination control procedures throughout the long-term (100+ days) cultivation process.
Multiomic & Electrophysiological Validation
High-standard quality control tools, including single-cell RNA-seq, proteomics, and MEA measurement, to quantify and evaluate the quality of every batch.
Documentation & Traceability
Assessment and approval of all cell bank origins and reagents by our internal quality assurance service to meet international research standards.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Case Study
The conventional CSC method for culturing human whole‑brain organoids (hBOs) requires multiple culture devices and repeated organoid transfer, which is cumbersome and prone to mechanical damage and contamination. The AIOMP microfluidic platform integrates the entire workflow into a single chip and supports complete differentiation of hBOs without transfer. By comparing the AIOMP and CSC methods, the study examined indicators including diameter, aspect ratio, coefficient of variation, and neural rosette morphology of hBOs at different stages. The results demonstrate that the AIOMP improves the homogeneity, reproducibility, and efficiency of neurogenesis during hBO formation, providing an optimized strategy for the standardized culture of whole‑brain organoids.
Fig.1 Evaluation of the homogeneity and reproducibility of brain organoid formation in the AIOMP.1
Customer Reviews
FAQs
Q: How do your organoids compare to animal models for neurotoxicity?
A: Unlike animal models, our organoids utilize human iPSCs, capturing human-specific drug responses and avoiding the evolutionary differences in the subventricular zone that often lead to false negatives in rodent studies.
Q: Can you handle custom iPSC lines provided by the client?
A: Yes. We have a robust protocol for integrating client-provided lines, including a thorough characterization phase to ensure the cells are suitable for 3D differentiation.
Q: What makes the AIOMP system better than a standard bioreactor?
A: The AIOMP system provides an "All-in-One" environment that eliminates the mechanical stress of transferring organoids between different vessels, resulting in higher morphological homogeneity and batch-to-batch reproducibility.
Q: Is it possible to model the blood-brain barrier (BBB) interaction?
A: Yes, our platform allows for the co-culture of endothelial cells to simulate BBB interfaces, providing insights into drug permeability and transport mechanisms within the organoid environment.
Q: What is the typical level of maturation achieved?
A: Our organoids reach structural milestones comparable to the second trimester of human fetal development, featuring functional synapses, glial populations, and organized cortical layering.
Creative Biolabs offers a suite of Whole-Brain Organoid services, ranging from custom disease modeling to high-throughput multiomic profiling. Our STEMOD™ platform is designed to provide the reproducibility and human-relevance required for modern CNS drug discovery.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Zhao, Wen, et al. "All-in-one generation and multiomic profiling of human whole brain organoid on a millifluidic plate." Materials Today Bio (2025): 102653. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1016/j.mtbio.2025.102653.
For Research Use Only. Not For Clinical Use.